David Guwatudde (BStat, MSc, PhD); is a Professor of Epidemiology and Biostatistics at the School of Public Health, Makerere University, Kampala, Uganda. He has long experience and expertise in implementing effectiveness evaluation studies in Uganda. He has implemented epidemiologic studies in non-communicable diseases (diabetes and hypertension), tuberculosis (TB), and nutritional morbidities in HIV. In recent years he has been the Uganda Principal Investigator (PI) on a randomized, double blinded placebo controlled trial that aimed at determining whether one recommended dietary allowance (RDA) dose of oral multivitamin supplements (including vitamins B-complex, C, and E), given daily for 18 months: (1) improves immune reconstitution (indicated by CD4 cell count); (2) improves weight gain, and/or (3) improves quality of life. Most recently he has been the Uganda country PI on a multi-country effectiveness randomized trial to evaluate the added benefit of specified community interventions onto health facility interventions, for prevention and management of type 2 diabetes. In this study, we designed and tested innovative context relevant interventions for integration and improvement of prevention and care for type 2 diabetes at primary health care levels.
Further, working closely with the Department of Non-Communicable Diseases of Uganda’s Ministry of Health, he is Co-PI on countrywide Non-Communicable Diseases Risk Factor STEPS surveys in Uganda, the first one conducted in 2014, and another to be conducted in 2022. The national surveys are meant to provide benchmark data on the prevalence of risk factors for NCDs in Uganda, to monitor trends in these, and to inform formulation and as well as evaluation of effectiveness of interventions for NCDs in the country.
Areas of Expertise and or interest:
- Evaluation of the effectiveness of health interventions,
- Epidemiology of non-communicable disease